Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Extracorporeal therapy for dabigatran removal in the treatment of acute bleeding: a single center experience.

Singh T, Maw TT, Henry BL, Pastor-Soler NM, Unruh ML, Hallows KR, Nolin TD.

Clin J Am Soc Nephrol. 2013 Sep;8(9):1533-9. doi: 10.2215/CJN.01570213. Epub 2013 May 23.

2.

Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran.

Bouchard J, Ghannoum M, Bernier-Jean A, Williamson D, Kershaw G, Weatherburn C, Eris JM, Tran H, Patel JP, Roberts DM.

Clin Toxicol (Phila). 2015 Mar;53(3):156-63. doi: 10.3109/15563650.2015.1004580. Epub 2015 Feb 8.

PMID:
25661675
3.

Removal of dabigatran by hemodialysis.

Chang DN, Dager WE, Chin AI.

Am J Kidney Dis. 2013 Mar;61(3):487-9. doi: 10.1053/j.ajkd.2012.08.047. Epub 2012 Dec 5.

PMID:
23219111
4.

Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose.

Chen BC, Sheth NR, Dadzie KA, Smith SW, Nelson LS, Hoffman RS, Winchester JF.

Am J Kidney Dis. 2013 Sep;62(3):591-4. doi: 10.1053/j.ajkd.2013.02.361. Epub 2013 Apr 16.

PMID:
23597859
5.

[Hemodialysis to remove anticoagulant dabigatran during emergencies].

Carrizo A, Campbell S.

Medicina (B Aires). 2014;74(2):121-3. Spanish.

6.

Clinical experience of life-threatening dabigatran-related bleeding at a large, tertiary care, academic medical center: a case series.

Ross B, Miller MA, Ditch K, Tran M.

J Med Toxicol. 2014 Jun;10(2):223-8. doi: 10.1007/s13181-013-0364-1.

7.

Safe use of hemodialysis for dabigatran removal before cardiac surgery.

Wanek MR, Horn ET, Elapavaluru S, Baroody SC, Sokos G.

Ann Pharmacother. 2012 Sep;46(9):e21. doi: 10.1345/aph.1R081. Epub 2012 Aug 7.

PMID:
22872748
8.

[Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery].

Bachellerie B, Ruiz S, Conil JM, Crognier L, Seguin T, Georges B, Fourcade O.

Ann Fr Anesth Reanim. 2014 Jan;33(1):44-6. doi: 10.1016/j.annfar.2013.11.011. Epub 2013 Dec 28. French.

PMID:
24378048
9.

Hemorrhagic complications associated with dabigatran use.

Chen BC, Viny AD, Garlich FM, Basciano P, Howland MA, Smith SW, Hoffman RS, Nelson LS.

Clin Toxicol (Phila). 2012 Nov;50(9):854-7. doi: 10.3109/15563650.2012.721888. Epub 2012 Sep 12.

PMID:
22970730
10.

Treatment of dabigatran-associated bleeding: case report and review of the literature.

Harinstein LM, Morgan JW, Russo N.

J Pharm Pract. 2013 Jun;26(3):264-9. doi: 10.1177/0897190012465955. Epub 2012 Nov 16. Review.

PMID:
23160864
11.

Ischemic stroke and intestinal bleeding under dabigatran in metabolic myopathy.

Finsterer J, Stöllberger C, Paul G, Bastovansky A.

Cardiovasc Ther. 2013 Dec;31(6):e111-4. doi: 10.1111/1755-5922.12044.

PMID:
24279385
12.

Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.

Berger R, Salhanick SD, Chase M, Ganetsky M.

Ann Emerg Med. 2013 Apr;61(4):475-9. doi: 10.1016/j.annemergmed.2013.02.008.

PMID:
23522810
13.

CHA2DS2-VASc and HAS-BLED scores and activated partial thromboplastin time for prediction of high plasma concentration of dabigatran at trough.

Owada S, Tomita H, Kinjo T, Ishida Y, Itoh T, Sasaki K, Horiuchi D, Kimura M, Sasaki S, Okumura K.

Thromb Res. 2015 Jan;135(1):62-7. doi: 10.1016/j.thromres.2014.10.025. Epub 2014 Nov 4.

PMID:
25466835
14.

Effective elimination of dabigatran by haemodialysis. A phase I single-centre study in patients with end-stage renal disease.

Khadzhynov D, Wagner F, Formella S, Wiegert E, Moschetti V, Slowinski T, Neumayer HH, Liesenfeld KH, Lehr T, Härtter S, Friedman J, Peters H, Clemens A.

Thromb Haemost. 2013 Apr;109(4):596-605. doi: 10.1160/TH12-08-0573. Epub 2013 Feb 7.

PMID:
23389759
15.

The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran.

Alikhan R, Rayment R, Keeling D, Baglin T, Benson G, Green L, Marshall S, Patel R, Pavord S, Rose P, Tait C.

Emerg Med J. 2014 Feb;31(2):163-8. doi: 10.1136/emermed-2012-201976. Epub 2013 Feb 22. Review.

16.

Bleeding events and activated partial thromboplastin time with dabigatran in clinical practice.

Kawabata M, Yokoyama Y, Sasano T, Hachiya H, Tanaka Y, Yagishita A, Sugiyama K, Nakamura T, Suzuki M, Isobe M, Hirao K.

J Cardiol. 2013 Aug;62(2):121-6. doi: 10.1016/j.jjcc.2013.03.010. Epub 2013 May 14.

17.

[Dabigatran as cause of severe gastrointestinal bleeding in a Jehovah's Witness patient].

Holm J, Taskiran M.

Ugeskr Laeger. 2013 Feb 4;175(6):334-6. Danish.

PMID:
23402236
18.

A case of dabigatran-associated acute renal failure.

Shafi ST, Negrete H, Roy P, Julius CJ, Sarac E.

WMJ. 2013 Aug;112(4):173-5; quiz 176.

19.

Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.

Wychowski MK, Kouides PA.

Ann Pharmacother. 2012 Apr;46(4):e10. doi: 10.1345/aph.1Q747. Epub 2012 Apr 10.

PMID:
22496474
20.

Dabigatran and kidney disease: a bad combination.

Knauf F, Chaknos CM, Berns JS, Perazella MA.

Clin J Am Soc Nephrol. 2013 Sep;8(9):1591-7. doi: 10.2215/CJN.01260213. Epub 2013 Jul 18. Review.

Supplemental Content

Support Center